BARD ASSOCIATES INC

13F Filings History

Latest 13F report
Q4 2024 - Feb 6, 2025
Value $
$294M
Signature - Title
Molly Wheeler - Compliance Consultant
Location
Chicago, IL
Summary
This page shows a list of all the recent 13F filings made by BARD ASSOCIATES INC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BARD ASSOCIATES INC reported 180 stock holdings with total value $294M as of Q4 2024. Top holdings included ENSG, TPZ, COHR, AMPG, and FIP.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 180 $294M +$19.7M -$31.3M -$11.6M ENSG, TPZ, COHR, AMPG, FIP 13F-HR 2/6/2025, 12:27 PM
Q3 2024 177 $293M +$11M -$6.19M +$4.82M ENSG, FIP, COHR, MAMA, WLDN 13F-HR 11/6/2024, 03:24 PM
Q2 2024 172 $259M +$5.43M -$13.6M -$8.18M ENSG, FIP, COHR, MAMA, AROC 13F-HR 8/12/2024, 12:00 PM
Q1 2024 173 $276M +$12.6M -$17.3M -$4.66M ENSG, FIP, COHR, USPH, ACU 13F-HR 5/13/2024, 10:53 AM
Q4 2023 171 $261M +$10.2M -$17.5M -$7.3M ENSG, SMID, CELH, FIP, MAMA 13F-HR 2/13/2024, 09:56 AM
Q3 2023 190 $240M +$7.8M -$2.83M +$4.97M ENSG, CELH, USAC, MAMA, FIP 13F-HR 11/13/2023, 10:29 AM
Q2 2023 185 $258M +$13.5M -$5.98M +$7.47M ENSG, USPH, COHR, FIP, CELH 13F-HR 8/11/2023, 11:55 AM
Q1 2023 190 $242M +$10.9M -$6.18M +$4.68M ENSG, CELH, USPH, USAC, FIP 13F-HR 5/12/2023, 10:09 AM
Q4 2022 194 $232M +$13.6M -$3.41M +$10.2M ENSG, CELH, USAC, SMID, FIP 13F-HR 2/10/2023, 09:35 AM
Q3 2022 185 $221M +$18.8M -$2.2M +$16.6M ENSG, CELH, SMID, TTP, USAC 13F-HR 11/9/2022, 12:33 PM
Q2 2022 181 $229M +$13.9M -$885K +$13.1M ENSG, IIVI, USPH, CELH, CSV 13F-HR 8/11/2022, 11:15 AM
Q1 2022 181 $276M +$8.66M -$1.64M +$7.03M ENSG, IIVI, CSV, USPH, TTP 13F-HR 5/11/2022, 10:10 AM
Q4 2021 181 $304M +$9.81M -$5.32M +$4.49M SMID, ENSG, IIVI, CSV, CELH 13F-HR 2/14/2022, 10:45 AM
Q3 2021 176 $296M +$22M -$15.8M +$6.23M ENSG, IIVI, CELH, USPH, JYNT 13F-HR 11/12/2021, 09:52 AM
Q2 2021 174 $306M +$29.6M -$19.1M +$10.5M ENSG, IIVI, USPH, JYNT, OSS 13F-HR 8/12/2021, 11:15 AM
Q1 2021 158 $277M +$10.9M -$16.1M -$5.14M ENSG, CELH, IIVI, OSS, WLDN 13F-HR 5/13/2021, 11:24 AM
Q4 2020 152 $253M +$18.6M -$12.2M +$6.38M CELH, IIVI, ENSG, WLDN, BEEM 13F-HR 2/11/2021, 09:54 AM
Q3 2020 152 $186M +$11.9M -$3.31M +$8.6M CELH, ENSG, IIVI, WLDN, USPH 13F-HR 11/12/2020, 11:00 AM
Q2 2020 154 $180M +$12.6M -$6.31M +$6.29M IIVI, WLDN, USPH, ENSG, CELH 13F-HR 8/13/2020, 11:49 AM
Q1 2020 156 $133M +$3.81M -$3.07M +$743K IIVI, WLDN, ENSG, PCYO, USPH 13F-HR 5/13/2020, 11:55 AM
Q4 2019 163 $196M +$7.53M -$5.56M +$1.97M USPH, WLDN, IIVI, ENSG, PCYO Restatement 2/13/2020, 11:29 AM
Q3 2019 164 $193M +$12M -$7.56M +$4.39M USPH, WLDN, IIVI, ENSG, ECC 13F-HR 11/14/2019, 11:32 AM
Q2 2019 161 $200M +$13.7M -$3.11M +$10.6M USPH, WLDN, ENSG, IIVI, ECC 13F-HR 8/13/2019, 04:02 PM
Q1 2019 167 $198M +$4.62M -$5.45M -$832K WLDN, USPH, IIVI, ENSG, KWR 13F-HR 5/13/2019, 01:30 PM
Q4 2018 168 $173M +$10.2M -$7.33M +$2.88M WLDN, USPH, IIVI, ENSG, KWR 13F-HR 2/13/2019, 02:57 PM
Q3 2018 170 $216M +$7.94M -$4.31M +$3.63M IIVI, USPH, WLDN, ENSG, KWR 13F-HR 11/14/2018, 11:06 AM
Q2 2018 175 $213M +$11.8M -$6.1M +$5.72M IIVI, WLDN, USPH, ENSG, KMG 13F-HR 8/15/2018, 10:29 AM
Q1 2018 175 $200M +$8.3M -$6.89M +$1.41M IIVI, WLDN, USPH, CSV, USAC 13F-HR 5/14/2018, 12:58 PM
Q4 2017 174 $208M +$6.31M -$6.88M -$569K IIVI, USPH, WLDN, USAC, KWR 13F-HR 2/13/2018, 12:14 PM
Q3 2017 176 $212M +$2.78M -$3.61M -$834K IIVI, WLDN, EVIXXXX, HDSN, USPH 13F-HR 11/14/2017, 10:55 AM
Q2 2017 187 $220M +$10.6M -$3.06M +$7.58M IIVI, WLDN, HDSN, EVIXXXX, USPH 13F-HR 8/10/2017, 02:57 PM
Q1 2017 182 $213M +$10.8M -$11.8M -$919K IIVI, WLDN, USPH, EVIXXXX, ACU 13F-HR 5/12/2017, 04:09 PM
Q4 2016 175 $213M +$7.6M -$9.82M -$2.22M IIVI, USPH, WLDN, HDSN, CSV 13F-HR 2/14/2017, 11:45 AM
Q3 2016 169 $202M +$5.97M -$3.46M +$2.51M IIVI, USPH, DHXM, USAC, HDSN 13F-HR 11/14/2016, 02:17 PM
Q2 2016 169 $188M +$7.48M -$3.73M +$3.75M USPH, DHXM, TYL, IIVI, CSV 13F-HR 8/11/2016, 01:33 PM
Q1 2016 163 $174M +$14.6M -$3.42M +$11.2M IIVI, DHXM, SRCL, USPH, CSV 13F-HR 5/12/2016, 04:43 PM
Q4 2015 159 $169M +$10.3M -$8.49M +$1.77M TYL, DHXM, USPH, IIVI, SRCL 13F-HR 2/12/2016, 12:54 PM
Q3 2015 163 $174M +$7.54M -$3.9M +$3.64M SRCL, TYL, DHXM, CSV, IIVI 13F-HR 11/12/2015, 11:52 AM
Q2 2015 169 $194M +$5.35M -$7.16M -$1.81M SRCL, TYL, USPH, IIVI, CSV 13F-HR 8/14/2015, 10:13 AM
Q1 2015 172 $209M +$6.45M -$14.8M -$8.39M SRCL, TYL, CSV, IIVI, USPH 13F-HR 5/15/2015, 04:10 PM
Q4 2014 174 $214M +$11.3M -$3.04M +$8.23M TYL, SRCL, SPA, CSV, BCPC Restatement 2/13/2015, 01:22 PM
Q3 2014 170 $214M +$43.8M -$1.51M +$42.3M TYL, SRCL, TPLMQ, EPM, SPA 13F-HR 11/13/2014, 02:05 PM
Q2 2014 187 $252M +$15.3M -$3.58M +$11.7M DHXMF, TYL, SRCL, EPM, TPLMQ 13F-HR 8/12/2014, 01:55 PM
Q1 2014 181 $236M +$3.64M -$5.68M -$2.04M EPM, TYL, SRCL, SPA, DHXMF 13F-HR 5/9/2014, 11:59 AM
Q4 2013 179 $239M TYL, EPM, DHXMF, SRCL, SPA 13F-HR 2/12/2014, 02:51 PM